MedTrace Logo

Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer

NCT00629863 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2013-08-07

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures, such as endoscopic ultrasound, may help doctors learn the extent of stomach cancer or esophageal cancer.

PURPOSE: This randomized clinical trial is studying how well endoscopic ultrasound works in diagnosing cancer in patients with localized stomach cancer or esophageal cancer.

Conditions

Interventions

DRUG

cisplatin

DRUG

fluorouracil

OTHER

questionnaire administration

PROCEDURE

diagnostic endoscopic procedure

PROCEDURE

neoadjuvant therapy

PROCEDURE

quality-of-life assessment

PROCEDURE

therapeutic conventional surgery

PROCEDURE

therapeutic endoscopic surgery

PROCEDURE

ultrasound imaging

RADIATION

radiation therapy

RADIATION

radioisotope therapy

Sponsors & Collaborators

  • North Wales Organisation for Randomised Trials in Health

    lead OTHER

Principal Investigators

  • Ken Park, MD · North Wales Organisation for Randomised Trials in Health

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2009-09-30
Completion
2010-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00629863 on ClinicalTrials.gov